Surface activity of surfactant spiked with vitamin A

Drug Design, Development and Therapy

Volumn , Issue 2, 2008, Pages 145-150

  Bronshtein, Vadim ^a   Venkatesh, Vugranam ^a   Aulakh, Jas ^a   Chessex, Philippe ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Drug delivery; Surface tension; Surfactant; Vitamin A

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; ISOTRETINOIN; LUNG SURFACTANT; RETINOIC ACID; RETINOL ACETATE; RETINOL PALMITATE;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; DRUG SOLUBILITY; LUNG ALVEOLUS SURFACE TENSION; LUNG DYSPLASIA; MISCIBILITY; VITAMIN SUPPLEMENTATION;

EID: 77953672815     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Allwood MC, Martin HJ. 2000. The photodegradation of vitamins A and E in parenteral nutrition mixtures during infusion. Clin Nutr, 19:339-342
2. Ambalavan N, Wu TJ, Tyson JE, et al. 2003. A comparison of three vitamin A dosing regimens in extremely-low-birth-weight-infants. J Pediatr, 142:656-661 (Pubitemid 36737169)
3. Ambalavanan N, Kennedy K, Tyson J, et al. 2004. Survey of vitamin A supplementation for extremely-low-birth-weight infants: is clinical practice consistent with the evidence? J Pediatr, 145:304-307 (Pubitemid 39165675)
4. Bernhard W, Mottaghian J, Gebert A, et al. 2000. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium. Am J Respir Crit Care Med, 162:1524-1533
5. Biesalski HK, Reifen R, Furst RP, et al. 1999. Retinyl palmitate supplementation by inhalation of an aerosol improves vitamin A status of preschool children in Gondar (Ethiopia). Br J Nutr, 82:179-182 (Pubitemid 29438386)
6. Bronstein V, Khashu M, Singh A, et al. 2005. Exploring a novel mode of vitamin A supplementation: intratracheal administration with surfactant [abstract]. Pediatr Res, 57:2507.
7. Brooks AD, Tong W, Benedetti F, et al. 2000. Inhaled aerosolization of all-trans-retinoic acid for targeted pulmonary delivery. Cancer Chemother Pharmacol, 46:313-318
8. D'Angio CT, Maniscalco WM. 2004. Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies. Pediatric Drugs, 6:303-330 (Pubitemid 39423221)
9. Dahl AR, Grossi IM, Houchens DP, et al. 2000. Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res, 6:3015-3024
10. Darlow BA, Graham PJ. 2002. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev, 4:CD000501.
11. Eggert LD, Rusho WJ, MacKay MW, et al. 1982. Calcium and phosphorus compatibility in parenteral nutrition solutions for neonates. Am J Hosp Pharm, 39:49-53.
12. Enhorning G. 1977. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol, 43:198-203.
13. Enhorning G. 2001. Pulmonary surfactant function studied with the pulsating bubble surfactometer (PBS) and the capillary surfactometer (CS). Comp Biochem Biophysiol, 129:221-226
14. Francisko A, Chakaraborty J, Yunus M, et al. 1993. Acute toxicity of vitamin A given with vaccine in infancy. Lancet, 342:526-527
15. Haas C, Genzel-Boroviczeny O, Koletzko B. 2002. Losses of vitamin A and E in parenteral nutrition suitable for premature infants. Eur J Clin Nutr, 56:906-912
16. Hustead VA, Gutcher GR, Anderson SA, et al. 1984. Relationship of vitamin A (retinol) status to lung disease in the preterm infant. J Pediatr, 105:610-615
17. Kohlhaufl M, Haussinger K, Stanzel F, et al. 2002. Inhalation of aerosolized vitamin A: reversibility of metaplasia and dysplasia of human respiratory epithelia-a prospective pilot study. Eur J Med Res, 7:72-78
18. Lavoie JC, Chessex P, Rouleau T, et al. 2007. Shielding parenteral multivitamins from light increases vitramin A and E concentration in lung of newborn guinea pigs. Clinical Nutr, 26:341-347
19. Maden M, Hind M. 2004. Retionoic acid in alveolar development, maintenance and regeneration. Phil Trans R Soc Lond, B359:799-808. (Pubitemid 38673748)
20. McMillan D, Chernick V, Finer N, et al. 1995. Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group. J Pediatr, 126:S90-8.
21. Ozer EA, Kumral A, Ozer E, et al. 2005. Effect of retinoic acid on oxygen induced lung injury in the newborn rat. Pediatr Pulmonol, 39:35-40.
22. Shenai JP, Chytil F, Stahlman MT. 1985. Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatr Res, 19:185-188
23. Smith VC, Zupancic JA, MvCormick MC, et al. 2004. Rehospitalisation in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr, 144:799-803.
24. Snyder JM, Jenkins-Moore M, Jackson SK, et al. 2005. Alveolarization in retinoic acid receptor-beta-deficient mice. Pediatr Res, 57:384-391
25. Stenmark KR, Abman SH. 2005. Lung vascular development: implication for the pathogenesis of bronchopulmonary dysplasia. Ann Rev Physiol, 67:623-661
26. Tyson JE, Wright LL, Oh W, et al. 1999. Vitamin A supplementation for extremely-low-birthweight infants: National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med, 340:1962-1968
27. Wardle SP, Hughes A, Chen S, et al. 2001. Randomized controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung diseases. Arch Dis Child Fetl Neonatal Ed, 84:F10-13.
28. Wong JC, McDougal AR, Tofan M, et al. 2006. Doubling calcium and phosphate concentrations in neonatal parenteral nutrition solutions using monobasic potassium phosphate. J Am Coll Nutr, 25:70-77